Clinical trial
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With…
NCT00296296 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00296296 |
|---|---|
| Title | Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) |
| Official title | Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen. |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplant, Diabetes Mellitus, Type 2, Diabetic Nephropathy |
| Intervention type | Behavioral, Drug |
| Interventions | Cyclosporin, Tacrolimus, 'Diabetes Education / Management' |
| Enrollment | 29 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2014 |
| Completion | Oct 1, 2014 |
| First posted | Feb 24, 2006 |
| Last update posted | Oct 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: